Ongoing Learning With Transcatheter Pulmonary Valve Replacement: Incremental Benefits Comparing Apples to Oranges
- PMID: 35057988
- DOI: 10.1016/j.jcin.2021.12.001
Ongoing Learning With Transcatheter Pulmonary Valve Replacement: Incremental Benefits Comparing Apples to Oranges
Keywords: congenital heart disease; right ventricular outflow tract dysfunction; transcatheter pulmonary valve replacement.
Conflict of interest statement
Funding Support and Author Disclosures Dr Fleming is site principal investigator at Duke for the COMPASSION S3 and COMPASSION S3 PAS sponsored by Edwards Lifesciences and for the Harmony valve post-approval study sponsored by Medtronic. Dr Chamberlain is a sub-investigator for both the COMPASSION S3 PAS (Edwards) and Harmony valve PAS (Medtronic).
Comment on
-
Echocardiographic Assessment of Melody Versus Sapien Valves Following Transcatheter Pulmonary Valve Replacement.JACC Cardiovasc Interv. 2022 Jan 24;15(2):165-175. doi: 10.1016/j.jcin.2021.11.002. JACC Cardiovasc Interv. 2022. PMID: 35057987
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical